Viking Therapeutics, Inc.
VKTXW
VKTXW was delisted on the 8th of April, 2021.
3 hedge funds and large institutions have $342K invested in Viking Therapeutics, Inc. in 2020 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 2 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
56% less capital invested
Capital invested by funds: $781K → $342K (-$439K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$33.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.01K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PWAM
1
Park West Asset Management
San Francisco,
California
| $291K | – | – | – |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $43K | -$33.2K | -7,280 | -34% |
|
|
3
UBS Group
Zurich,
Switzerland
| $8K | -$1.01K | -222 | -8% |
|
VKTXW Hedge Fund Activity: Q1 2020 in Review
3 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics, Inc. (VKTXW) for Q1 2020, worth a combined $342K — down 56% from $781K a quarter earlier.
Fund positioning in VKTXW was balanced in Q1 2020: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.
The largest seller was Susquehanna International Group, cutting an estimated $33.2K.
- 3 institutional investors held Viking Therapeutics, Inc. (VKTXW) as of Q1 2020, unchanged from Q4 2019.
- Funds reported $342K of Viking Therapeutics, Inc. stock for Q1 2020, down 56% quarter-over-quarter.
- 0 funds opened new Viking Therapeutics, Inc. positions in Q1 2020 and 0 closed out.
- The largest Viking Therapeutics, Inc. seller in Q1 2020 was Susquehanna International Group, an estimated $33.2K sold.
Based on aggregated 13F filings for Q1 2020.